#ASCO23@asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert@urotoday@PCFnews
@DrSpratticus Absolutely agree dr Spratt. So in your practice do you actually recommend not to use HT just for FIR with gleason 6 , and one IR factor ?? All the rest of FIR and UIR 6 months HT ???
When title is not concordant with original paper outcomes ……………..
Multimodality care improves treatment outcomes for aggressive prostate cancer - ecancer https://t.co/bOWRqU8W91